Cladribine induces long lasting oligoclonal bands disappearance in relapsing multiple sclerosis patients: 10-year observational study
Author:
Publisher
Elsevier BV
Subject
Clinical Neurology,Neurology,General Medicine
Reference23 articles.
1. Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta;Annunziata;J. Neurol. Sci.,2006
2. The treatment of chronic progressive multiple sclerosis with cladribine;Beutler;Proc. Natl. Acad. Sci. U.S.A.,1996
3. Progression and CSF inflammation after eradication of oligoclonal bands in an MS patient treated with allogeneic hematopoietic cell transplantation for follicular lymphoma;Braendstrup;Case. Rep. Neurol.,2012
4. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement;Freedman;Arch. Neurol.,2005
5. A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis;Giovannoni;N. Engl. J. Med.,2010
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Early use of cladribine tablets for relapsing-remitting multiple sclerosis: Expert opinion;Meditsinskiy sovet = Medical Council;2024-08-14
2. Cladribine tablets in Relapsing-Remitting Multiple Sclerosis preferentially target B-cells;2024-03-29
3. Modification of T- and B-cell-associated immuno-pathologic mechanisms in multiple sclerosis by disease modifying therapies: Achievements and opportunities;Handbook of Clinical Neurology;2024
4. Bioavailable central nervous system disease-modifying therapies for multiple sclerosis;Frontiers in Immunology;2023-11-29
5. The elusive nature of the oligoclonal bands in multiple sclerosis;Journal of Neurology;2023-11-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3